Kennebec Savings Bank’s Pfizer PFE Stock Holding History

Kennebec Savings Bank’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62.6K	Buy	2,600 +1,000	+63%	+$26.2K	0.05%	146
2026 Q1	$44.9K	Hold	1,600	–	–	0.04%	143
2025 Q4	$39.8K	Hold	1,600	–	–	0.03%	155
2025 Q3	$40.8K	Hold	1,600	–	–	0.04%	155
2025 Q2	$38.8K	Sell	1,600 -796	-33%	-$18.6K	0.04%	151
2025 Q1	$60.7K	Buy	2,396 +493	+26%	+$12.9K	0.06%	130
2024 Q4	$51K	Buy	1,903 +171	+10%	+$4.64K	0.05%	136
2024 Q3	$50.1K	Buy	+1,732	New	+$50.5K	0.05%	150

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Kennebec Savings Bank's PFE Position: Q2 2026 in Review

Kennebec Savings Bank increased its Pfizer (PFE) stake by 63% in Q2 2026, buying an estimated $26.2K and bringing the position to 2,600 shares worth $62.6K. The position accounts for 0.05% of the portfolio, ranked #146.

Kennebec Savings Bank first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. 1,016 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Kennebec Savings Bank held 2,600 shares of Pfizer worth $62.6K as of Q2 2026.
Kennebec Savings Bank bought 1,000 Pfizer shares in Q2 2026, an estimated $26.2K.
Pfizer made up 0.05% of Kennebec Savings Bank's portfolio in Q2 2026, its #146 holding.
Kennebec Savings Bank first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
1,016 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kennebec Savings Bank's 13F filing for Q2 2026, filed 13 Jul 2026.